AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Feb 17 2022
Moderna CEO sees potential end of coronavirus pandemic on horizon, though says it will never be eradicated
Moderna CEO Stephane Bancel on Wednesday said the end of the coronavirus pandemic could be on the horizon.
“I think that is a reasonable scenario,” he told CNBC when asked whether he thought the pandemic was winding down. “There’s an 80% chance that as omicron evolves or SarsCov-2 virus evolves, we are going to see less and less virulent viruses.”
Moderna along with PfizerNew York Daily News
May 18 2020
Moderna, the Massachusetts biotechnology company behind a leading effort to create a coronavirus vaccine, announced promising early results from its first human safety tests Monday. The company plans to launch a large clinical trial in July aimed at showing whether the vaccine works.
The company reported that in eight patients who had been followed for a month and a half, the vaccine atWashington Post
Apr 28 2022
Moderna seeks emergency use authorization for Covid-19 vaccine for children ages 6 months through 5 years
Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said Thursday.
"We believe mRNA-1273 will be able to safely protect these children against SARS-CoV-2, which is so important in our continued fight against COVID-19, and will be especially welcomed by parents andCNN (Online News)
Nov 19 2021
A Centers for Disease Control and Prevention panel on Friday unanimously approved recommending booster shots of the Pfizer-BioNTech and Moderna vaccines for all adults.
The CDC panel said anyone 18 or above can get a third shot, while recommending that Americans over the age of 50 should get one. A final decision by the agency is expected later Friday.
Earlier in the day, theNew York Post (News)
Mar 04 2021
There's good news about "Moderna arm," the raised, sometimes itchy red rash some people get a week or so after being vaccinated with Moderna's COVID-19 vaccine.
There were concerns people who experienced the annoying rash might have a worse reaction with the second dose. A report published Wednesday finds that's not the case – and most don't have any reaction at all the second time.USA TODAY
Feb 17 2021
A new report published in the New England Journal of Medicine on Wednesday suggests that Pfizer-BioNTech's Covid-19 vaccine can protect people against concerning new coronavirus variants, including one first seen in South Africa called B.1.351.
For the study, researchers at Pfizer and the University of Texas Medical Branch genetically engineered versions of the virus to carry some ofCNN (Online News)
Jul 27 2020
A nationwide study begins Monday to find out if a potential coronavirus vaccine, developed by Cambridge-based Moderna and the National Institute of Allergy and Infectious Diseases, is safe and effective in preventing people from getting COVID-19.
The clinical trial will enroll 30,000 people, with Brigham and Women’s Hospital leading the New England section of the trial.
TheThe Boston Globe
Nov 22 2021
MSNBC host Joy Reid got her facts wrong when she attempted to fact-check GOP lawmakers who credited Operation Warp Speed for progress in the development of a coronavirus vaccine.
Moderna announced on Monday that interim analysis from a late-stage clinical trial showed its vaccine is 94.5% effective. On Wednesday, Pfizer followed that up with an announcement that its vaccine had beenFox News (Online News)
Mar 31 2021
The National Institutes of Health has started testing a new coronavirus vaccine from Moderna designed to protect against a problematic variant first found in South Africa, the agency said Wednesday.
The phase one trial, led and funded by the NIH’s National Institute of Allergy and Infectious Diseases, will test how safe and effective the new shot is against the variant — known as B.1.CNBC
Mar 16 2021
Children have now received their first doses of Moderna's COVID-19 vaccine, as the company studies the safety and effectiveness of the vaccine for kids ages 6 months to less than 12 years old.
In the study, researchers will give two injections 28 days apart of either the Moderna vaccine or a saline placebo to children. Kids who get the vaccine will receive one of three possible doses,NPR (Online News)